Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human (tested or 100% immunogen sequence identity)
Specificity and Use
RFPL2 antibody was raised against synthetic peptide C-TTDAPVRPGEAK from the C-terminus of human RFPL2 (NP_006596.2; NP_001091997.2; NP_001153017.1; NP_001153018.1; NP_001092005.1; NP_006595.1). Percent identity by BLAST analysis: Human, Gorilla (100%); Baboon (92%); Gibbon, Horse (83%).
LS-E25493 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C55385. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Human RFPL2. This is expected to recognise both RFPL2 (NP_006596.2; NP_001091997.2; NP_001153017.1; NP_001153018.1) and RFPL3 (NP_001092005.1; NP_006595.1), which are virtually identical. Variants (NP_001153017.1; NP_001153018.1) encode the same isoform.